136 related articles for article (PubMed ID: 38700373)
41. Diagnostic evaluation of paediatric autoimmune lymphoproliferative immunodeficiencies (ALPID): a prospective cohort study.
Hägele P; Staus P; Scheible R; Uhlmann A; Heeg M; Klemann C; Maccari ME; Ritterbusch H; Armstrong M; Cutcutache I; Elliott KS; von Bernuth H; Leahy TR; Leyh J; Holzinger D; Lehmberg K; Svec P; Masjosthusmann K; Hambleton S; Jakob M; Sparber-Sauer M; Kager L; Puzik A; Wolkewitz M; Lorenz MR; Schwarz K; Speckmann C; Rensing-Ehl A; Ehl S;
Lancet Haematol; 2024 Feb; 11(2):e114-e126. PubMed ID: 38302222
[TBL] [Abstract][Full Text] [Related]
42. Defective FAS-Mediated Apoptosis and Immune Dysregulation in Gaucher Disease.
Miano M; Madeo A; Cappelli E; Lanza F; Lanza T; Stroppiano M; Terranova P; Venè R; Bleesing JJH; Di Rocco M
J Allergy Clin Immunol Pract; 2020; 8(10):3535-3542. PubMed ID: 32702516
[TBL] [Abstract][Full Text] [Related]
43. Abnormally differentiated CD4+ or CD8+ T cells with phenotypic and genetic features of double negative T cells in human Fas deficiency.
Rensing-Ehl A; Völkl S; Speckmann C; Lorenz MR; Ritter J; Janda A; Abinun M; Pircher H; Bengsch B; Thimme R; Fuchs I; Ammann S; Allgäuer A; Kentouche K; Cant A; Hambleton S; Bettoni da Cunha C; Huetker S; Kühnle I; Pekrun A; Seidel MG; Hummel M; Mackensen A; Schwarz K; Ehl S
Blood; 2014 Aug; 124(6):851-60. PubMed ID: 24894771
[TBL] [Abstract][Full Text] [Related]
44. [Non-malignant, non-infectious lymphoproliferation: challenges in the diagnosis and treatment of autoimmune lymphoproliferative syndrome].
Molnár E; Kovács G; Varga L; Tasnády S; Bors A; Tankó L; Csabán D; Kapócs K; Nemes-Nagy Z; Andrikovics H
Orv Hetil; 2022 Jan; 163(4):123-131. PubMed ID: 35066491
[TBL] [Abstract][Full Text] [Related]
45. Identification of new Fas mutations in a patient with autoimmune lymphoproliferative syndrome (ALPS) and eosinophilia.
Aspinall AI; Pinto A; Auer IA; Bridges P; Luider J; Dimnik L; Patel KD; Jorgenson K; Woodman RC
Blood Cells Mol Dis; 1999; 25(3-4):227-38. PubMed ID: 10575548
[TBL] [Abstract][Full Text] [Related]
46. Ocular Inflammatory Disorders in Autoimmune Lymphoproliferative Syndrome (ALPS).
Ucar D; Kim JS; Bishop RJ; Nussenblatt RB; Rao VK; Sen HN
Ocul Immunol Inflamm; 2017 Oct; 25(5):703-709. PubMed ID: 27229379
[TBL] [Abstract][Full Text] [Related]
47. Co-inherited mutations of Fas and caspase-10 in development of the autoimmune lymphoproliferative syndrome.
Cerutti E; Campagnoli MF; Ferretti M; Garelli E; Crescenzio N; Rosolen A; Chiocchetti A; Lenardo MJ; Ramenghi U; Dianzani U
BMC Immunol; 2007 Nov; 8():28. PubMed ID: 17999750
[TBL] [Abstract][Full Text] [Related]
48. Inherited and acquired death receptor defects in human Autoimmune Lymphoproliferative Syndrome.
Rieux-Laucat F
Curr Dir Autoimmun; 2006; 9():18-36. PubMed ID: 16394653
[TBL] [Abstract][Full Text] [Related]
49. Autoimmune lymphoproliferative syndrome mimicking chronic active Epstein-Barr virus infection.
Nomura K; Kanegane H; Otsubo K; Wakiguchi H; Noda Y; Kasahara Y; Miyawaki T
Int J Hematol; 2011 Jun; 93(6):760-764. PubMed ID: 21626105
[TBL] [Abstract][Full Text] [Related]
50. Elevated vitamin B₁₂ levels in autoimmune lymphoproliferative syndrome attributable to elevated haptocorrin in lymphocytes.
Bowen RA; Dowdell KC; Dale JK; Drake SK; Fleisher TA; Hortin GL; Remaley AT; Nexo E; Rao VK
Clin Biochem; 2012 Apr; 45(6):490-2. PubMed ID: 22306884
[TBL] [Abstract][Full Text] [Related]
51. Defective anti-polysaccharide response and splenic marginal zone disorganization in ALPS patients.
Neven B; Bruneau J; Stolzenberg MC; Meyts I; Magerus-Chatinet A; Moens L; Lanzarotti N; Weller S; Amiranoff D; Florkin B; Bader-Meunier B; Leverger G; Ferster A; Chantrain C; Blanche S; Picard C; Molina TJ; Brousse N; Durandy A; Rizzi M; Bossuyt X; Fischer A; Rieux-Laucat F
Blood; 2014 Sep; 124(10):1597-609. PubMed ID: 24970930
[TBL] [Abstract][Full Text] [Related]
52. Combined germline and somatic human FADD mutations cause autoimmune lymphoproliferative syndrome.
Pellé O; Moreno S; Lorenz MR; Riller Q; Fuehrer M; Stolzenberg MC; Maccari ME; Lenoir C; Cheminant M; Hinze T; Hebart HF; König C; Schvartz A; Schmitt Y; Vinit A; Henry E; Touzart A; Villarese P; Isnard P; Neveux N; Landman-Parker J; Picard C; Fouyssac F; Neven B; Grimbacher B; Speckmann C; Fischer A; Latour S; Schwarz K; Ehl S; Rieux-Laucat F; Rensing-Ehl A; Magérus A
J Allergy Clin Immunol; 2024 Jan; 153(1):203-215. PubMed ID: 37793571
[TBL] [Abstract][Full Text] [Related]
53. Janus Kinase Inhibitor Tofacitinib Shows Potent Efficacy in a Mouse Model of Autoimmune Lymphoproliferative Syndrome (ALPS).
Yokoyama S; Perera PY; Terawaki S; Watanabe N; Kaminuma O; Waldmann TA; Hiroi T; Perera LP
J Clin Immunol; 2015 Oct; 35(7):661-7. PubMed ID: 26453583
[TBL] [Abstract][Full Text] [Related]
54. Using biomarkers to predict the presence of FAS mutations in patients with features of the autoimmune lymphoproliferative syndrome.
Caminha I; Fleisher TA; Hornung RL; Dale JK; Niemela JE; Price S; Davis J; Perkins K; Dowdell KC; Brown MR; Rao VK; Oliveira JB
J Allergy Clin Immunol; 2010 Apr; 125(4):946-949.e6. PubMed ID: 20227752
[No Abstract] [Full Text] [Related]
55. Soluble Fas and Fas ligand and prognosis in children with acute lymphoblastic leukemia.
Fathi M; Amirghofran Z; Shahriari M
Med Oncol; 2012 Sep; 29(3):2046-52. PubMed ID: 21528407
[TBL] [Abstract][Full Text] [Related]
56. Sirolimus is effective in autoimmune lymphoproliferative syndrome-type III: A pedigree case report with homozygous variation PRKCD.
Gu H; Chen Z; Ma J; Wang J; Zhang R; Wu R; Wang T
Int J Immunopathol Pharmacol; 2021; 35():20587384211025934. PubMed ID: 34187243
[TBL] [Abstract][Full Text] [Related]
57. Cord blood soluble Fas ligand and pediatric atopic dermatitis.
Su KW; Chen PC; Wang IJ
Allergy Asthma Proc; 2011; 32(5):366-71. PubMed ID: 22195689
[TBL] [Abstract][Full Text] [Related]
58. Synergistic defects of novo FAS and homozygous UNC13D leading to autoimmune lymphoproliferative syndrome-like disease: A 10-year-old Chinese boy case report.
Gu H; Ma J; Chen Z; Wang J; Zhang R; Wu R
Gene; 2018 Sep; 672():45-49. PubMed ID: 29864493
[TBL] [Abstract][Full Text] [Related]
59. Advances in autoimmune lymphoproliferative syndromes.
Madkaikar M; Mhatre S; Gupta M; Ghosh K
Eur J Haematol; 2011 Jul; 87(1):1-9. PubMed ID: 21447005
[TBL] [Abstract][Full Text] [Related]
60. Autoimmune lymphoproliferative syndrome (ALPS). Case report and family history.
Ries F; Ferster A; Rieux-Laucat F; Biwer A; Dicato M
Bull Soc Sci Med Grand Duche Luxemb; 2010; (2):271-8. PubMed ID: 20882745
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
